Posted by Michael Wonder on 17 Jun 2022
Public consultation: draft 2022-23 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP
17 June 2022 - Consultation on the content of the draft 2022-23 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme and designated vaccines on the National Immunisation Program is now open.
This CRIS sets out the fees that will apply for the 2022-23 financial year and provides information on how the Department of Health implements cost recovery.
